Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
WuXi Biologics and OncoC4 Establish Exclusive CDMO Partnership 2021-05-27 08:30
Advanced Micro- and Nanofluidics to Revolutionize the Point-of-care Diagnostic Industry 2021-05-27 02:59
Inteleos Announces MedGlobal and Global Ultrasound Institute as MissionPOCUS Selection for 2021 2021-05-26 23:36
Boan Biotech Grants AstraZeneca Exclusive Rights to Promote Boyounuo(R) (Bevacizumab Injection) in Specific County Markets of China 2021-05-26 23:03
TransThera announces collaboration with Roche to evaluate TT-00420 as part of a novel combination to treat GI cancers in China 2021-05-26 21:00
Gracell Biotechnologies Hosting Key Opinion Leader Webinar on High Risk Multiple Myeloma, Treatment Challenges and Dual-Targeting CAR-T with Overnight Manufacturing - a Novel Approach for Treatment of Multiple Myeloma 2021-05-26 21:00
IT Tech Packaging, Inc. Officially Obtains FDA Approval for Surgical Mask Products 2021-05-26 20:00
Merck Accelerates Scale Up of Lipids to Meet Covid-19 Demand 2021-05-26 20:00
RedHill Biopharma Receives Allowances for U.S. Patent Applications Covering Opaganib and RHB-107 for COVID-19 2021-05-26 19:12
TIAN RUIXIANG Holdings Ltd Signs Insurance Brokerage Services Agreement for Cooperation in Cancer Prevention Insurance 2021-05-26 18:30
Prosit Sole Biotechnology Initiates First-In-Human Clinical Trial of Novel Interferon Lambda Chimera in US 2021-05-26 16:10
IntoCare Medical Completes Up to 100 million RMB Round D Financing, Doubling Down on Powered Stapling Industry 2021-05-26 12:20
How Guiyang Leverages Big Data Analytics in Healthcare? 2021-05-26 11:08
TCI Co., Ltd. named as one of Asia's fastest growing companies by The Financial Times 2021-05-26 11:07
Texas Cardiac Arrhythmia Institute leader participates in clinical trial for catheter that may reduce complication risk during cardiac ablation 2021-05-26 10:13
UNNC students win international awards with sustainable design works 2021-05-26 09:00
Sinovant Sciences and Nabriva Therapeutics Announce Positive Topline Results from Phase 3 Trial of Lefamulin in Chinese Adults with Community Acquired Bacterial Pneumonia (CABP) 2021-05-26 05:00
I Peace's cell manufacturing facility "Peace Engine Kyoto" receives third-party certification as US cGMP compliant: the facility now meets the standard for both the US and Japanese markets 2021-05-26 03:00
Aussie LegalTech Startup Goes Global With COVID-19 Diagnosis Tool 2021-05-25 22:25
Nanoform and Celanese Explore Ways to Enhance Drug Delivery 2021-05-25 21:45
1 515 516 517 518 519 1508